试点随机试验提示GLP-1停药后结构化支持或有助限制体重回升
Pilot trial suggests structured support may help limit weight regain after GLP-1 treatment
发表于《Obesity Science & Practice》的一项试点随机试验提示,停用GLP-1后接受数字健康应用或医疗定制餐者,四个月体重回升低于常规护理组。对照组体重回升估计为10.75%,数字健康应用组为3.60%,医疗定制餐组为3.58%,但调查显示组间在饮食质量、感知健康、依从性和满意度上无显著差异。研究团队认为,需要基于证据的策略帮助停用GLP-1的患者维持减重成果。
Glucagon-like peptide-1 (GLP-1) receptor agonists are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference and other factors—and often leads to rapid weight regain. Results from a pilot randomized trial, published in Obesity Science & Practice, suggest that structured support may attenuate early weight gain after GLP-1 cessation.
In the trial, 39 adults with prior GLP-1-induced weight loss were randomly assigned to four months of usual care, a digital wellness application or medically tailored meals beginning at the time of GLP-1 cessation.
Surveys showed that diet quality, perceived health, adherence and satisfaction did not differ significantly by group, though some estimates suggested possible trends favoring the wellness application.
Relative to the control group, the other groups experienced less weight gain. Over four months, participants in the control group gained an estimated 10.75% of their body weight, compared with 3.60% in the wellness application group and 3.58% in the medically tailored meals group.
"People invest significant time and effort in improving their health and achieving weight loss," said corresponding author Kelseanna Hollis-Hansen, Ph.D., MPH, of Tufts University Food is Medicine Institute.
"We need evidence-based strategies to support them if and when they discontinue GLP-1 medication, so they can maintain those gains and continue building long-term health, vitality and well-being."
More information
Preventing Weight Regain After GLP‑1 Therapy Discontinuation: A Pilot Randomized Controlled Trial, Obesity Science & Practice (2026). DOI: 10.1002/osp4.70194
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Pilot trial suggests structured support may help limit weight regain after GLP-1 treatment (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-trial-limit-weight-regain-glp.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com